IDEAS home Printed from https://ideas.repec.org/a/pkp/tijobi/v2y2013i3p59-67id1497.html
   My bibliography  Save this article

Serum Malondialdehyde, Gamma Glutamyl Transferase and Prostate Specific Antigen as Markers of Cancer of the Prostate

Author

Listed:
  • Dolapo Pius OPARINDE
  • Adeniran Samuel ATIBA
  • Patrick Temi ADEGUN
  • Temitope Adeola ‘Niran-Atiba

Abstract

OBJECTIVE: Prostate specific antigen (PSA) has been found not to be specific for the screening of cancer of the prostate (CaP). We determined serum levels of prostate specific antigen, malondialdehyde (MDA) and gamma glutamyl transferase in patients with newly diagnosed CaP and benign prostatic hyperplasia (BPH) DESIGN: A cross sectional study SETTING: It was carried out in the urology clinic of Ladoke Akintola University of Technology Teaching Hospital, Osogbo, Nigeria SUBJECTS: A total of 67, 50 and 70 men for patients with BPH, CaP and healthy age matched control respectively were recruited. RESULTS: Serum MDA(µmol/l) was observed to be significantly higher in CaP(2.05±0.64) than in BPH (1.68±0.41); p<0.05. There were also a significant higher value of serum MDA in CaP(p<0.01) and BPH(p<0.05) when compared with control (0.06±0.09). Significant higher serum levels of PSA (ng/ml) was observed in patients with CaP (70.25±50.40) than patients with BPH (22.77±10.17); p<0.01. Serum PSA(ng/ml) also was found to be significantlly higher in CaP(p<0.01) as well as BPH (p<0.01) when compared with control (0.76±0.54). There was a significant positive correlation between serum MDA and PSA in patients with CaP(r=0.701;p<0.05) and BPH (r=0.651;p<0.05). There were no significant differences in serum GGT among the study groups CONCLUSSION: Serum level of malonaldehyde may be used as a marker in screening for prostate cancer as a compliment to PSA. Gamma glutamyl transferase may have no place in prostatic cancer detection.

Suggested Citation

  • Dolapo Pius OPARINDE & Adeniran Samuel ATIBA & Patrick Temi ADEGUN & Temitope Adeola ‘Niran-Atiba, 2013. "Serum Malondialdehyde, Gamma Glutamyl Transferase and Prostate Specific Antigen as Markers of Cancer of the Prostate," The International Journal of Biotechnology, Conscientia Beam, vol. 2(3), pages 59-67.
    • Handle: RePEc:pkp:tijobi:v:2:y:2013:i:3:p:59-67:id:1497
    as

    Download full text from publisher

    File URL: https://archive.conscientiabeam.com/index.php/57/article/view/1497/2086
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pkp:tijobi:v:2:y:2013:i:3:p:59-67:id:1497. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dim Michael (email available below). General contact details of provider: https://archive.conscientiabeam.com/index.php/57/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.